Emerging within the pharmaceutical landscape, retatrutide appears a promising breakthrough in the management field . This innovative dual stimulator targeting both GLP-1 and GIP receptors has shown impressive efficacy in clinical investigations, suggesting a enhanced ability to encourage fat decrease and address associated cardiovascular risks . Wh